secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001193125-25-311305
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical files Form 25 to complete Nasdaq delisting after Chapter 11 bankruptcy
--------------------------------------------------------------------------------

- Filed Form 25 on Dec 8, 2025 to delist from Nasdaq and deregister under Section 12(b); effective no earlier than Dec 18, 2025.
- Nasdaq delisting notice received Nov 24, 2025 after Chapter 11 filing (Case No. 25-12109); trading suspended Dec 1, 2025.
- Common stock trades on OTC Pink under symbol CLSDQ since Dec 1, 2025.
- Deregistration will reduce SEC reporting obligations 90 days after Form 25 effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525311305/0001193125-25-311305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525311305/d98628d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-311305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer